Participant characteristics
| Characteristic | Sample N=1109 | ‘Physically active and non-obese’ n=493; 45.9% | ‘Physically active and obese’ n=118; 10.7% | ‘Physically inactive and non-obese’ n=343; 29.9% | ‘Physically inactive and obese’ n=155; 13.5% |
|---|---|---|---|---|---|
| Age (years)* | 51.0 (16.5) | 46.0 (14.7) | 51.1 (13.2) | 55.2 (18.4) | 58.4 (15.0) |
| Body mass index (kg/m2)* | 27.3 (4.8) | 25.1 (2.7) | 33.4 (3.0) | 25.5 (3.2) | 34.3 (3.9) |
| By sex | |||||
| Men | 27.6 (4.2) | 25.4 (2.6) | 33.3 (2.5) | 26.3 (2.6) | 34.2 (3.1) |
| Women | 27.0 (5.4) | 24.6 (2.9) | 33.5 (3.6) | 24.8 (3.4) | 34.4 (4.4) |
| Waist circumference (cm)* | 92.9 (13.9) | 87.3 (10.5) | 106.9 (9.5) | 89.6 (12.2) | 109.1 (11.3) |
| By sex | |||||
| Men | 98.4 (12.1) | 92.2 (9.0) | 112.0 (7.6) | 97.6 (9.4) | 114.1 (9.0) |
| Women | 87.2 (13.5) | 81.1 (8.9) | 101.2 (7.9) | 83.3 (10.1) | 104.8 (11.4) |
| Ethnicity† | |||||
| White | 1055 (94.2) | 470 (94.7) | 112 (94.3) | 324 (93.4) | 149 (94.7) |
| Non-white | 54 (5.8) | 23 (5.3) | 6 (5.7) | 19 (6.6) | 6 (5.3) |
| Income† | |||||
| Low | 287 (24.0) | 92 (16.7) | 31 (24.3) | 111 (30.6) | 53 (33.5) |
| Intermediate | 364 (33.5) | 159 (32.9) | 43 (38.5) | 107 (32.0) | 55 (35.6) |
| High | 458 (42.5) | 242 (50.4) | 44 (37.2) | 125 (37.4) | 47 (30.9) |
| Sex† | |||||
| Men | 523 (50.2) | 257 (55.4) | 60 (53.5) | 142 (43.5) | 64 (45.0) |
| Women | 586 (49.8) | 236 (44.6) | 58 (46.5) | 201 (56.5) | 91 (55.0) |
| Any prescribed medication† | |||||
| No | 503 (47.7) | 278 (58.0) | 57 (49.3) | 129 (40.1) | 39 (28.5) |
| Yes | 606 (52.3) | 215 (42.0) | 61 (50.7) | 214 (59.9) | 116 (71.5) |
| Accelerometer wear-time* (number of minutes/valid day) | 867.7 (72.1) | 873.2 (68.9) | 870.4 (77.1) | 854.9 (74.7) | 875.1 (69.3) |
| Total accumulated moderate-to-vigorous-intensity physical activity time* (number of minutes/valid day) | 30.8 (25.8) | 47.2 (25.5) | 41.3 (18.6) | 11.5 (6.4) | 9.7 (5.9) |
| Moderate-to-vigorous-intensity physical activity time in bouts of ≥10 min* (number of minutes/valid day) | 10.8 (16.2) | 39.8 (22.0) | 36.4 (11.7) | 5.6 (6.1) | 4.5 (5.8) |
| Number of valid days† | |||||
| 4 | 46 (4.5) | 17 (3.9) | 9 (8.0) | 12 (3.5) | 8 (6.1) |
| 5 | 80 (7.5) | 32 (6.7) | 5 (4.3) | 31 (9.3) | 12 (8.5) |
| 6 | 209 (19.7) | 89 (18.4) | 20 (18.0) | 77 (24.1) | 23 (15.8) |
| 7 | 774 (68.3) | 355 (71.0) | 84 (69.7) | 223 (63.1) | 112 (69.6) |
| Glycated haemoglobin (HbA1c) (mmol/mol)* | 38.1 (7.3) | 36.1 (4.9) | 38.5 (4.8) | 39.2 (9.2) | 41.9 (8.7) |
| (%)* | 5.63 (0.67) | 5.45 (0.45) | 5.67 (0.44) | 5.74 (0.84) | 5.98 (0.79) |
All analyses controlled for primary sampling units, clustering and survey weights.
*Continuous variable; mean (SD).
†Categorical variable; n (proportion (%)).